{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:33:39Z","timestamp":1785202419141,"version":"3.55.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-11-2-0174"],"award-info":[{"award-number":["W81XWH-11-2-0174"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-07-2-0067"],"award-info":[{"award-number":["W81XWH-07-2-0067"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["Y1-AI-2642-12"],"award-info":[{"award-number":["Y1-AI-2642-12"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1032144"],"award-info":[{"award-number":["OPP1032144"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OP1146996"],"award-info":[{"award-number":["OP1146996"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196397","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T17:30:41Z","timestamp":1524850241000},"page":"e0196397","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-0960","authenticated-orcid":true,"given":"Siriwat","family":"Akapirat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitraporn","family":"Karnasuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinan","family":"Madnote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hathairat","family":"Savadsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surawach","family":"Rittiroongrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraporn","family":"Puangkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Phogat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faruk","family":"Sinangil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Excler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viseth","family":"Ngauy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicos","family":"Karasavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of The RV305 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMp1313771","article-title":"Ending AIDS\u2014Is an HIV Vaccine Necessary?","volume":"370","author":"AS Fauci","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jri.2007.02.002","article-title":"The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission","volume":"77","author":"R Kaul","year":"2008","journal-title":"J Reprod Immunol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e11366","DOI":"10.1371\/journal.pone.0011366","article-title":"Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies","volume":"5","author":"M Ghosh","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.virol.2009.06.011","article-title":"Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4+ T-lymphocytes","volume":"391","author":"MJ Stax","year":"2009","journal-title":"Virology"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.4049\/jimmunol.165.9.5170","article-title":"Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells","volume":"165","author":"C Devito","year":"2000","journal-title":"J Immunol"},{"issue":"4","key":"ref6","first-page":"413","article-title":"Cross-Clade HIV-1-Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1-Exposed","volume":"30","author":"C Devito","year":"2002","journal-title":"Cross-Clade HIV-1-Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1-Exposed"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00126334-200008010-00001","article-title":"Modified Wick Method Using Weck-Cel Sponges for Collection of Human Rectal Secretions and Analysis of Mucosal HIV Antibody","volume":"24","author":"PA Kozlowski","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2249.1996.36742.x","article-title":"Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation","volume":"104","author":"WH Kutteh","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.4049\/jimmunol.175.6.4127","article-title":"Human Male Genital Tract Secretions: Both Mucosal and Systemic Immune Compartments Contribute to the Humoral Immunity","volume":"175","author":"Z Moldoveanu","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jri.2009.07.005","article-title":"Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection","volume":"83","author":"J Mestecky","year":"2009","journal-title":"J Reprod Immunol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1128\/JVI.02533-09","article-title":"Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein","volume":"84","author":"SW Barnett","year":"2010","journal-title":"MF59 Adjuvant. J Virol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges","volume":"34","author":"M Bomsel","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime\u2013boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"AD Cristillo","year":"2011","journal-title":"J Gen Virol"},{"issue":"23","key":"ref14","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"ML Robb","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"ref16","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1089\/aid.2012.0103","article-title":"The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120","volume":"28","author":"N Karasavvas","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection","volume":"9","author":"S Zolla-Pazner","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"e53629","DOI":"10.1371\/journal.pone.0053629","article-title":"Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC\/AIDSVAX HIV-1 Vaccine Efficacy Trial","volume":"8","author":"S Zolla-Pazner","year":"2013","journal-title":"PLoS ONE"},{"issue":"7420","key":"ref20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"M Rolland","year":"2012","journal-title":"Nature"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jix099","article-title":"Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial","volume":"215","author":"S Rerks-Ngarm","year":"2017","journal-title":"J Infect Dis"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1089\/aid.2016.0204","article-title":"Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens","volume":"33","author":"C Karnasuta","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/JVI.68.1.400-410.1994","article-title":"Presentation of native epitopes in the V1\/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains","volume":"68","author":"SC Kayman","year":"1994","journal-title":"J Virol"},{"issue":"19","key":"ref24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0264-410X(98)00182-0","article-title":"Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1V2 domain of HIV-1 gp120","volume":"16","author":"A Pinter","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1089\/aid.2015.0034","article-title":"IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1\/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I\/II Vaccine Trials Using Different Vaccine Regimens","volume":"31","author":"N Karasavvas","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/21645515.2016.1276138","article-title":"Progress in HIV vaccine development","volume":"13","author":"Hsu DC","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1128\/CVI.00230-14","article-title":"Nonneutralizing Functional Antibodies: a New \u201cOld\u201d Paradigm for HIV Vaccines","volume":"21","author":"J-L Excler","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"14","key":"ref28","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/CDLI.4.5.624-626.1997","article-title":"Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus","volume":"4","author":"AS Mohamed","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"e23136","DOI":"10.1371\/journal.pone.0023136","article-title":"Performance of Swabs, Lavage, and Diluents to Quantify Biomarkers of Female Genital Tract Soluble Mucosal Mediators","volume":"6","author":"CS Dezzutti","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jri.2007.01.006","article-title":"Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites","volume":"73","author":"J Mestecky","year":"2007","journal-title":"J Reprod Immunol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0733-8627(20)30540-X","article-title":"Sexually related trauma","volume":"6","author":"RF Geist","year":"1988","journal-title":"Emerg Med Clin North Am"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1095\/biolreprod.105.041079","article-title":"Transport of IgG across the Blood-Luminal Barrier of the Male Reproductive Tract of the Rat and the Effect of Estradiol Administration on Reabsorption of Fluid and IgG by the Epididymal Ducts","volume":"73","author":"RA Knee","year":"2005","journal-title":"Biol Reprod"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Z Li","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2004.05.007","article-title":"Human Neonatal Fc Receptor Mediates Transport of IgG into Luminal Secretions for Delivery of Antigens to Mucosal Dendritic Cells","volume":"20","author":"M Yoshida","year":"2004","journal-title":"Immunity"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ebiom.2016.11.024","article-title":"Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection","volume":"14","author":"RD Astronomo","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.0105-2896.2005.00290.x","article-title":"Mucosal immunoglobulins","volume":"206","author":"JM Woof","year":"2005","journal-title":"Immunol Rev"},{"issue":"22","key":"ref38","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.167.9.5185","article-title":"The J Chain Is Essential for Polymeric Ig Receptor-Mediated Epithelial Transport of IgA","volume":"167","author":"F-E Johansen","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12977-014-0109-5","article-title":"Are anti-HIV IgAs good guys or bad guys?","volume":"11","author":"M Zhou","year":"2014","journal-title":"Retrovirology"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/mi.2009.110","article-title":"Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses","volume":"3","author":"MP Cranage","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/viro.1999.0093","article-title":"Oral DNA Vaccination Promotes Mucosal and Systemic Immune Responses to HIV Envelope Glycoprotein","volume":"267","author":"H Kaneko","year":"2000","journal-title":"Virology"},{"issue":"20","key":"ref43","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1128\/JVI.05441-11","article-title":"A Neonatal Fc Receptor-Targeted Mucosal Vaccine Strategy Effectively Induces HIV-1 Antigen-Specific Immunity to Genital Infection","volume":"85","author":"L Lu","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.170.1.495","article-title":"HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses","volume":"170","author":"G Sakaue","year":"2003","journal-title":"J Immunol"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1128\/JVI.78.15.8342-8348.2004","article-title":"Induction of Mucosal and Systemic Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) by Oral Immunization with Bovine Papillomavirus-HIV-1 gp41 Chimeric Virus-Like Particles","volume":"78","author":"H Zhang","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e328360eac6","article-title":"Anti-HIV IgA Isotypes: Differential Virion Capture and Inhibition of Transcytosis are Linked to Prevention of Mucosal R5 SHIV Transmission","volume":"27","author":"JD Watkins","year":"2013","journal-title":"AIDS"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T06:40:55Z","timestamp":1661064055000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196397"}},"subtitle":[],"editor":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196397","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}